All Articles on Moderna

• 
  Volunteers needed for COVID-19 booster trial

  NIAID-sponsored study includes Seattle in test for benefits of mixing different vaccine types.
• 
  ‘Fighting back’ against COVID-19: Remembering a historic trial

  Lisa Jackson, MD, MPH, Kaiser Permanente Washington senior investigator, recounts the genesis of a groundbreaking vaccine.
• 
  NIH-Moderna COVID-19 vaccine receives FDA Emergency Use Authorization

  The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.